Naperville, IL -- (SBWire) -- 07/12/2013 --Reportstack, provider of premium market research reports announces the addition of Allergy Partnering 2007-2013 market report to its offering
The Allergy Partnering 2007-2013 report provides understanding and access to the allergy partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in allergy partnering deals
Top allergy deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type
The Allergy Partnering 2007-2013 provides understanding and access to the allergy partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of allergy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors allergy technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases do not.
This data driven report contains over 80 links to online copies of actual allergy deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.
The initial chapters of this report provide an orientation of allergy partnering trends.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in allergy partnering since 2007, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.
Chapter 3 provides an overview of the leading allergy deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive directory of allergy partnering deals signed and announced since 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of allergy technologies and products.
Report scope
Allergy Partnering 2007-2013 is intended to provide the reader with an in-depth understanding and access to allergy trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
Trends in allergy dealmaking in the biopharma industry since 2007
Access to summary headline, upfront, milestone and royalty data
Access to over 80 allergy contract documents
The leading allergy deals by value since 2007
In Allergy Partnering 2007-2013, the available deals are listed by:
Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Reasons to Buy
Allergy Partnering 2007-2013 provides the reader with the following key benefits:
In-depth understanding of allergy deal trends since 2007
Access to summary headline, upfront, milestone and royalty data
Comprehensive access to over 80 actual allergy deals entered into by the worlds biopharma companies since 2007
Insight into key deal terms included in contracts, where disclosed
Understand the key deal terms companies have agreed in deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
To view the table of contents for this market research report please visit
http://www.reportstack.com/product/122307/allergy-partnering-2007-2013.html
Allergy Partnering 2007-2013